Sonim Technologies to Present at LD Micro Investor Conference
Get Alerts SONM Hot Sheet
Join SI Premium – FREE
Austin, Texas--(Newsfile Corp. - October 18, 2022) - Sonim Technologies (Nasdaq: SONM) today announced that management will participate at the following investor conference event during October 2022.
Event: LD Micro Main Event XV
Date: Wednesday, October 26, 2022
Presentation: 11:00 a.m. Pacific Time
Live stream: https://me22.mysequire.com/
Location: Luxe Sunset Boulevard Hotel, Los Angeles
Management will host individual investor meetings during the conference. To arrange a meeting with Sonim, please contact your conference representative. Investors may also contact Sonim investor relations at [email protected] to arrange an in-person meeting.
About Sonim Technologies, Inc.
Sonim Technologies is a leading U.S. provider of ultra-rugged mobile phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. We currently sell our ruggedized mobility solutions to several of the largest wireless carriers in the United States- including AT&T, T-Mobile and Verizon-as well as the three largest wireless carriers in Canada-Bell, Rogers and Telus Mobility. Our phones and accessories connect workers with voice, data and workflow applications in two end markets: industrial enterprise and public sector. Our ruggedized phones and accessories are sold through distributors in North America, South America and Europe. For more information, visit www.sonimtech.com.
Sonim Technologies Contacts
Sonim Technologies, Inc.
[email protected]
Matt Kreps, Managing Director
Darrow Associates Investor Relations
[email protected]
(214) 597-8200

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/140966
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CanPR Technology Ltd. Announces Board Resignation and Provides Corporate Update
- OGE Energy Corp. second quarter 2026 earnings webcast
- Laplace Announces FDA IDE Approval of TRIUMPH Pivotal Trial of Its Transcatheter Tricuspid Valve Replacement System
Create E-mail Alert Related Categories
Newsfile, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share